Skip to content
Drug recall · FDA · Published April 30, 2019

Direct Rx recalls Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC

FDA recalls Direct Rx Losartan Potassium 100mg tablets due to impurity NMBA above safe levels. Consumers with this specific product should stop using it.

🇺🇸 FDA recall #D-0018-2021DrugDirect Rx ›
Take action

Contact the company & request your remedy

Recalling firmDirect Rx94 Worldwide Dr, N/A · Dawsonville, GA 30534-6828
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Direct Rx is recalling 100mg Losartan Potassium tablets because FDA testing found an impurity (NMBA) at levels above the safe limit. This could pose health risks if taken regularly. Read more at govinfonow.com/recall/38868-direct-rx-losartan-potassium-100mg-tablets-recall-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38868-direct-rx-losartan-potassium-100mg-tablets-recall-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0018-2021

Cite this page

“Direct Rx Losartan Potassium 100mg Tablets Recall: Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38868-direct-rx-losartan-potassium-100mg-tablets-recall-impurity-risk. Based on FDA recall #D-0018-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0018-2021%22&limit=1).

Why it’s dangerous

FDA labs detected N-Methylnitrosobutyric acid (NMBA) in the medication at levels exceeding the safe daily intake. This impurity could cause health issues if taken regularly, as it's not present in safe amounts.

Who’s affected

People who have the specific 100mg Losartan Potassium tablets with NDC 61919-952-30 and lot number 27AU1801 are affected. Prescriptions for this medication are at risk.

How to tell if you have this one

Check for the 100mg Losartan Potassium tablets with NDC code 61919-952-30 and lot number 27AU1801. These were distributed by Direct Rx in Dawsonville, GA.

  • Brand
    Direct Rx
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using It Now

    Immediately stop using the recalled Losartan Potassium tablets as they contain an impurity that could cause health risks.

✎ GovInfoNow

Questions people ask

Is this product safe to take?

No, the FDA found an impurity (NMBA) in the product at levels above the safe limit, so it is not safe to take.

What should I do if I have this product?

Stop using it immediately and contact your doctor for alternative medication options.

How can I check if I have the recalled product?

Look for the NDC code 61919-952-30 and lot number 27AU1801 on the bottle label.

Take action

Contact Direct Rx

We’ve drafted a message you can send Direct Rx to request your refund or repair — edit it as you like.

Subject: Recall D-0018-2021 — Direct Rx Direct Rx

Hello,

I own a Direct Rx that is covered by recall D-0018-2021 from Direct Rx.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0018-2021 (April 30, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0018-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA